DELAYED GRAFT FUNCTION
Clinical trials for DELAYED GRAFT FUNCTION explained in plain language.
Never miss a new study
Get alerted when new DELAYED GRAFT FUNCTION trials appear
Sign up with your email to follow new studies for DELAYED GRAFT FUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a 2-Day infusion save transplanted kidneys?
Disease control Recruiting nowThis study tests if a drug called treprostinil can help protect a new kidney from injury during transplant surgery. About 20 adults receiving a deceased donor kidney will get the drug through an IV for two days, starting just before surgery. The goal is to see if it improves kidn…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE1, PHASE2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated May 26, 2026 04:06 UTC
-
Could a simple drug during kidney transplant prevent dialysis afterward?
Disease control Recruiting nowThis study tests if giving terlipressin during kidney transplant surgery helps maintain blood pressure better than standard drugs. About 150 adults with kidney failure will be randomly assigned to receive either terlipressin plus dobutamine or dobutamine alone. The goal is to see…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New drug could jumpstart transplanted kidneys
Disease control Recruiting nowThis study tests if a stomach acid drug called vonoprazan fumarate can prevent delayed graft function (DGF) after a kidney transplant. DGF is when the new kidney is slow to start working, often requiring dialysis. About 47 adults getting their first kidney transplant from a decea…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug aims to jumpstart transplanted kidneys in High-Risk patients
Disease control Recruiting nowThis study tests a drug called pegcetacoplan in adults who are getting a kidney transplant from a deceased donor and are at high risk for delayed graft function (when the kidney takes a while to start working). The goal is to see if the drug helps the kidney work sooner and reduc…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New drug aims to cut dialysis time after kidney transplant
Disease control Recruiting nowThis study tests if the drug ravulizumab can help transplanted kidneys start working sooner, reducing the need for dialysis after surgery. About 450 adults at high risk for delayed graft function will receive either the drug or a placebo. The main goal is to see how quickly patie…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC